ea0085p45 | Pituitary and Growth 1 | BSPED2022
Apperley Louise
, Dharmaraj Poonam
, Blair Joanne
, Ramakrishnan Renuka
, Das Urmi
, Didi Mohamed
, Laing Peter
, Yung Zoe
, Cassidy Kelly
, Blundell Pauline
, Jarvis Charlotte
, Parkinson Jennifer
, Senniappan Senthil
Background: Pubertal progression is inhibited in central precocious puberty with the use of gonadotropin releasing hormone (GnRH) analogues. They are usually given every 10 to 12 weeks via an intramuscular depot, but more recently, a 6-monthly preparation has become available for clinical use.Aim: The aim of this project was to evaluate the efficacy and acceptability of 6-monthly triptorelin, a GnRH analogue, at a tertiary childrens hospital.<p...